Vanderbilt Health News Archive — Page 292 of 390

Close-up green microscopic-style illustration of spiky spherical particles clustered on a textured surface.
July 25, 2013

Pollen counts boost risk of rare drug reaction: study

High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.

Black-and-white Burroughs Wellcome Fund logo with the words “BURROUGHS WELLCOME FUND” and an outlined eye symbol.
July 24, 2013

Medical Center limited submission opportunity: Burroughs Wellcome Fund

Group portrait of nine medical professionals, most wearing white coats, with one person seated in a wheelchair in front, standing in an indoor reception area.
July 24, 2013

VU Stroke Center attains new level of certification

The Vanderbilt Stroke and Cerebrovascular Service has received advanced certification as a Comprehensive Stroke Center by The Joint Commission and the American Heart Association/American Stroke Association, one of only four in Tennessee.

A healthcare professional in a white coat offers a bowl of fruit to a seated person while holding a measuring device; a computer monitor and medical books are visible in the background.
July 19, 2013

Vanderbilt Nutrition and Diet Assessment Core established

The Vanderbilt Nutrition and Diet Assessment Core has been established to facilitate all types of human research.

Pregnant patient lies in a hospital bed while a clinician operates an ultrasound machine; the monitor displays an ultrasound scan.
July 18, 2013

Baby’s life-changing surgery, before birth

Portrait of a man in a dark suit and patterned tie against a warm brown background.
July 18, 2013

VU researchers ‘goldsmith’ new RSV vaccine approach

Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines.